AngioDynamics to Present at the J.P. Morgan Healthcare Conference

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Michael C. Greiner, Executive Vice President and Chief Financial Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Tuesday, January 8, 2019 in San Francisco, CA.

A live webcast of the presentation and Q&A breakout session will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

About AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories drainage products, thrombolytic products and venous products. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181220005716/en/

Investor Contact:
AngioDynamics, Inc.
Michael C. Greiner, Executive Vice President & CFO
(518) 795-1821

Source: AngioDynamics, Inc.

You May Also Be Interested In

• ZKH Group Limited Announces Second Quarter 2026 Unaudited Financial Results
• Fusion Just Got Its First Publicly Listed Company Advancing Fusion Toward Commercial Scale
• Nano Labs to Announce First Half of Fiscal Year 2026 Financial Results on August 28, 2026